WELL Health Technologies Corp
TSX:WELL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
EV/OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Enterprise Value to Operating Cash Flow (EV/OCF) ratio compares a company`s total enterprise value to its operating cash flow. It shows how much investors are paying for each dollar of the company`s operating cash flow, including both equity and debt.
Valuation Scenarios
If EV/OCF returns to its 3-Year Average (17.8), the stock would be worth CA$5.93 (43% upside from current price).
| Scenario | EV/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 12.5 | CA$4.15 |
0%
|
| 3-Year Average | 17.8 | CA$5.93 |
+43%
|
| 5-Year Average | 18.5 | CA$6.14 |
+48%
|
| Industry Average | 14.9 | CA$4.95 |
+19%
|
| Country Average | 11.9 | CA$3.97 |
-4%
|
Forward EV/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | EV/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| CA |
|
WELL Health Technologies Corp
TSX:WELL
|
1.1B CAD | 12.5 | -143.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
100.2B USD | 14.1 | 56.7 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
68.5B EUR | 10.5 | 13.2 | |
| US |
|
Cigna Corp
NYSE:CI
|
73.7B USD | 0 | 12.4 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
22.9B EUR | 12.4 | 18.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.1B EUR | 11.1 | 23.6 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22.1B USD | 14.5 | 21.7 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
21.8B USD | 16 | 24.8 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.9B EUR | 6.5 | 11.1 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.5B USD | -64.9 | -27.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.6B USD | 10.5 | 14.2 |
Market Distribution
| Min | 0 |
| 30th Percentile | 7.9 |
| Median | 11.9 |
| 70th Percentile | 19.5 |
| Max | 22 577.3 |
Other Multiples
WELL Health Technologies Corp
Glance View
In the digital age of healthcare, WELL Health Technologies Corp. emerges as a quiet but formidable innovator, weaving technology and wellness into a comprehensive ecosystem. Founded in 2010, the company has grown from its Canadian roots to become a major player in the health-tech landscape, driven by a mission to modernize and improve healthcare access. WELL Health operates primarily within the electronic medical records (EMR) sector, offering physicians and clinics a seamless transition from traditional paper-based systems to robust digital platforms. With a series of strategic acquisitions, WELL has expanded its portfolio to include telehealth services, medical services, and digital health applications, effectively building an integrated network that caters to both healthcare providers and patients. This blend of services positions WELL Health as a pioneer in overhauling how healthcare systems interact with technology, thereby laying the groundwork for a more efficient, patient-centric approach. WELL Health Technologies generates revenue through a multifaceted business model that hinges on its diverse array of service lines. The company earns by licensing its EMR software to clinics and practitioners, ensuring a steady stream of recurring revenue. Additionally, its telehealth services, which provide virtual healthcare consultations, have gained traction, especially amid the increased demand for remote healthcare solutions. The acquisition strategy further enriches WELL’s revenue sources, allowing it to tap into various niche markets such as cybersecurity for healthcare data and provider billing services. These services not only diversify WELL Health’s income streams but also enhance the value proposition to its users by offering a one-stop shop for healthcare solutions. Through a carefully orchestrated expansion, WELL Health Technologies continues to redefine the synergy between health and technology, anchoring itself firmly as a vital conduit in the ever-evolving healthcare domain.
